Revisiting flow augmentation bypass for cerebrovascular atherosclerotic vaso-occlusive disease: Single-surgeon series and review of the literature

OBJECTIVE: Despite advances in the nonsurgical management of cerebrovascular atherosclerotic steno-occlusive disease, approximately 15–20% of patients remain at high risk for recurrent ischemia. The benefit of revascularization with flow augmentation bypass has been demonstrated in studies of Moyamo...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelgadir, Jihad, Haskell-Mendoza, Aden P., Magno, Amanda R., Suarez, Alexander D., Antwi, Prince, Raghavan, Alankrita, Nelson, Patricia, Yang, Lexie Zidanyue, Jung, Sin-Ho, Zomorodi, Ali R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198506/
https://www.ncbi.nlm.nih.gov/pubmed/37205640
http://dx.doi.org/10.1371/journal.pone.0285982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198506/
https://www.ncbi.nlm.nih.gov/pubmed/37205640
http://dx.doi.org/10.1371/journal.pone.0285982

Ejemplares similares